1950KRW
29.77 BKRW
230.39 BKRW
8.13 M
About WHANIN PHARM
Sector
Headquarters
Seoul
Employees (FY)
645
Website
Founded
1978
ISIN
KR7016580003
FIGI
BBG000H0NTK9
Whan In Pharmaceutical Co., Ltd. engages in the manufacture and sale of medical supplies. Its products include psychotropic agent, medicine for circulating system and digestive ulcers, therapeutic for osteoporosis, pain killers, and others. The company was founded by Kwang-Sik, Lee on June 5, 1978 is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 016580 is 13730.00 KRW — it has decreased by 0.22% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange WHANIN PHARM stocks are traded under the ticker 016580.
WHANIN PHARM is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
WHANIN PHARM revenue for the last quarter amounts to 58.80 B KRW despite the estimated figure of 56.00 B KRW. In the next quarter revenue is expected to reach 57.50 B KRW.
Yes, you can track WHANIN PHARM financials in yearly and quarterly reports right on TradingView.
Like other stocks, 016580 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade WHANIN PHARM stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 645.00 employees. See our rating of the largest employees — is WHANIN PHARM on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. WHANIN PHARM EBITDA is 36.66 B KRW, and current EBITDA margin is 15.98%. See more stats in WHANIN PHARM financial statements.